Stay updated on AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision marker changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:00:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The study page now displays a 403 error page, replacing the previous content with an error layout. This blocks access to the trial details and location information shown on the page.
    Difference
    19%
    Check dated 2026-09-23T01:06:20.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.6 to v3.7.0, signaling a software update to the page. No study details or content are changed as a result.
    Difference
    0.1%
    Check dated 2026-09-16T00:15:11.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-09-01T19:34:53.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The sponsor is updated to Immedica Pharma AB, and the study overview has been refreshed to reflect a first-in-human, phase 1 dose-escalation trial of AEB1102 (Co-ArgI-PEG). New expansion cohorts were added for Cutaneous Melanoma, Uveal Melanoma, and Small Cell Lung Cancer, dosed at 0.33 mg/kg, with corresponding enrollment details and updated timelines.
    Difference
    3%
    Check dated 2026-08-11T15:17:38.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page metadata revision label updated from v3.6.3 to v3.6.4, indicating a small version bump.
    Difference
    0.0%
    Check dated 2026-07-28T05:41:41.000Z thumbnail image

Stay in the know with updates to AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AEB1102 Dose Escalation in Advanced Solid Tumors Clinical Trial page.